TMEM106A inhibits enveloped virus release from cell surface

Dexin Mao1,2, Feixiang Yan1,2, Xiaolin Zhang1

  • 1CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing 100101, China.

Iscience
|February 24, 2022
PubMed

Insights

Host factor TMEM106A acts as a novel antiviral defense, trapping enveloped viruses like HIV-1 to the cell surface. This conserved protein inhibits viral release, offering a new target for antiviral therapies.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Enveloped viruses are a significant threat to host organisms.
  • Virion release from host cells is a crucial stage in the viral life cycle and a target for host defense.
  • Understanding host factors that regulate viral release is key to developing antiviral strategies.

Purpose of the Study:

  • To investigate the role of host factor TMEM106A in the release of enveloped viruses.
  • To elucidate the mechanism by which TMEM106A inhibits viral particle release.
  • To assess the antiviral potential of TMEM106A and its orthologs against various enveloped viruses.

Main Methods:

  • Investigated the localization and function of TMEM106A in virus-producing cells.
  • Analyzed the interaction between TMEM106A, virion particles, and the plasma membrane.
  • Examined the effect of HIV-1 Env on TMEM106A antiviral activity.
  • Tested TMEM106A orthologs for antiviral activity against multiple enveloped viruses.

Main Results:

  • Host factor TMEM106A, a type II transmembrane protein, inhibits the release of enveloped viruses from the cell surface.
  • TMEM106A localizes to the plasma membrane and gets incorporated into HIV-1 virions.
  • Intermolecular interactions of TMEM106A's C-terminal domains trap virions to the cell surface.
  • HIV-1 Env partially suppresses TMEM106A's antiviral activity by interfering with these interactions.
  • TMEM106A orthologs exhibit potent antiviral activity against diverse enveloped viruses.

Conclusions:

  • TMEM106A is an evolutionarily conserved antiviral factor that restricts enveloped virus release.
  • The mechanism involves trapping virions to the cell surface via specific molecular interactions.
  • TMEM106A represents a promising target for developing broad-spectrum antiviral therapies.